$2.93-5.48%
2026-10-06 closeLoading chart…
Today's signals · No active technical signal.
Signal details →SAB Biotherapeutics last closed at $2.93 (-5.48%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -18.3×. Its overall grade ranks 300 of 740 stocks in Healthcare.
About this company
SAB Biotherapeutics last closed at $2.93 (-5.48%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 300/740
Valuation grade A
Related stocks
- Regeneron PharmaceuticalsCompetitor
항체·면역질환 바이오의약품 개발 경쟁사
- AmgenCompetitor
면역·염증 및 항체치료제 분야 대형 경쟁사
- Bristol Myers SquibbCompetitor
자가면역·면역학 신약 개발에서 경쟁하는 대형 제약사
About SAB Biotherapeutics
- What technical signals does SAB Biotherapeutics (SABS) have?
- SAB Biotherapeutics current technical signals: no active technical signal.
- Is SAB Biotherapeutics a cup-and-handle pattern?
- No. SAB Biotherapeutics has no valid Cup signal right now.
- What published figures are available for SAB Biotherapeutics?
- Market cap: $139.49M. Trailing 12 months PER: -18.3×. Latest quarter PBR: 1.09×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-07 dataset
Turn what you saw on this name into a strategy
Ask Q about SAB Biotherapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy